Erleada 240 MG Oral Tablet

RxCUI: 2630217
RxNorm name: Erleada 240 MG Oral Tablet
Display name: Erleada 240 MG Oral Tablet
Full name: Erleada 240 MG Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:22

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ERLEADA	APALUTAMIDE	Janssen Products, LP	d1cda4f7-cb33-46ea-b9ac-431f6452b1a5	2026-07-02	Warnings, Adverse reactions	Exact identifier rxcui: 2630217

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
d1cda4f7-cb33-46ea-b9ac-431f6452b1a5	Erleada 240 MG Oral Tablet [PSN] · apalutamide 240 MG Oral Tablet [Erleada] [SBD] · Erleada 240 MG Oral Tablet [SY]	3	28	These highlights do not include all the information needed to use ERLEADA safely and effectively. See full prescribing information for ERLEADA. ERLEADA ® (apalutamide) tablets, for oral use Initial U.S. Approval – 2018	20260310